当前位置:首页 - 行情中心 - 宁科生物(600165) - 财务分析 - 现金流量表

宁科生物

(600165)

  

流通市值:24.55亿  总市值:54.13亿
流通股本:7.33亿   总股本:16.16亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金179,011,913.2473,441,654.74266,517,034.73192,156,729.61
  收到的税费返还585,409.48578,534.551,282,914.85884,828.91
  收到其他与经营活动有关的现金8,863,699.5524,936.1113,021,730.2210,655,894.87
  经营活动现金流入小计188,461,022.2274,545,125.4280,821,679.8203,697,453.39
  购买商品、接受劳务支付的现金280,658,067.66160,538,881.64447,149,998.51349,119,819
  支付给职工以及为职工支付的现金77,966,256.6845,186,114.4127,470,141.6161,207,581.63
  支付的各项税费15,547,758.110,890,414.2228,493,087.1219,398,813.87
  支付其他与经营活动有关的现金17,287,546.442,441,962.4951,110,835.1410,456,094.01
  经营活动现金流出小计391,459,628.88219,057,372.75654,224,062.38440,182,308.51
  经营活动产生的现金流量净额-202,998,606.66-144,512,247.35-373,402,382.58-236,484,855.12
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额--1,140,0001,054,735
  投资活动现金流入的平衡项目--00
  投资活动现金流入小计--1,140,0001,054,735
  购建固定资产、无形资产和其他长期资产支付的现金51,043,349.925,073,192.49271,166,587.9945,171,315.35
  投资活动现金流出小计51,043,349.925,073,192.49271,166,587.9945,171,315.35
  投资活动产生的现金流量净额-51,043,349.9-25,073,192.49-270,026,587.99-44,116,580.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,241,323,635.2-
  取得借款收到的现金10,000,000-9,000,000284,000,000
  收到其他与筹资活动有关的现金104,964,570.21250,916.67431,322,190.5243,000,000
  筹资活动现金流入小计114,964,570.21250,916.671,681,645,825.72327,000,000
  偿还债务支付的现金7,800,0004,183,360.4352,720,00042,290,000
  分配股利、利润或偿付利息支付的现金8,614,415.324,276,725.61,692,371.564,188,922.14
  支付其他与筹资活动有关的现金113,546,348.288,832,694.74533,096,950.12250,000
  筹资活动现金流出小计129,960,763.617,292,780.77587,509,321.6846,728,922.14
  筹资活动产生的现金流量净额-14,996,193.39-17,041,864.11,094,136,504.04280,271,077.86
四、汇率变动对现金及现金等价物的影响-95,701.68-30,920.6199,229.2671,082.01
五、现金及现金等价物净增加额-269,133,851.63-186,658,224.54450,906,762.73-259,275.6
  加:期初现金及现金等价物余额459,096,777.85459,151,239.158,190,015.128,569,306.85
  期末现金及现金等价物余额189,962,926.22272,493,014.61459,096,777.858,310,031.25
补充资料:
  净利润-132,395,868.66--162,893,275.97-
  资产减值准备56,961,410.02-222,563,040.25-
  固定资产和投资性房地产折旧57,896,421.02-123,663,365.66-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧57,896,421.02-123,663,365.66-
  无形资产摊销1,473,564.52-3,723,346.68-
  长期待摊费用摊销381,767.05-1,099,204.72-
  处置固定资产、无形资产和其他长期资产的损失---3,657,114.21-
  固定资产报废损失--605,216.14-
  财务费用14,174,716.66-27,474,796-
  投资损失---340,988,904.61-
  递延所得税-254,421.27-1,903,259.04-
  其中:递延所得税资产减少-60,734.63-2,388,937.78-
    递延所得税负债增加-193,686.64--485,678.74-
  存货的减少-58,564,427.36--50,313,807.53-
  经营性应收项目的减少-79,848,407.28--45,678,247.98-
  经营性应付项目的增加-62,977,391--153,712,302.67-
  其他---643,737.88-
  现金的期末余额189,962,926.22-459,096,777.85-
  减:现金的期初余额459,096,777.85-8,190,015.12-
  现金及现金等价物的净增加额-269,133,851.63-450,906,762.73-
公告日期2026-08-292026-04-302026-04-242025-10-31
审计意见(境内)带强调事项段的无保留意见
TOP↑